Progress in prevention of prosthesis joint infection

doi:10.3877/cma.j.issn.1674-134X.2019.02.013

Abstract

Abstract:

For knee and hip joint deformity and dysfunction, joint replacement is the most effective and safe treatment for knee and hip terminal diseases. However this improvement of life quality of patient means there are many complications, including artificial joint infection which is the most serious complication after artificial joint replacement. In case of infection, it can bring huge body burden to patients and economic pressure. Prevention is the most cost-effective measure of joint infection. Therefore, it is necessary to understand the risk factors of infection in artificial joint replacement and take preventive measures in time. This article reviewed these problems.

Key words: Joint prosthesis, Infection, Prevention

Chongzun Zhu, Chuang Yang, Hao Shen. Progress in prevention of prosthesis joint infection[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2019, 13(02): 206-212,250.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgjwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-134X.2019.02.013

https://zhgjwkzz.cma-cmc.com.cn/EN/Y2019/V13/I02/206

References 88

[1]	Bozic KJ, Ward DT, Lau EC, et al. Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a case control study[J]. J Arthroplasty, 2014, 29(1): 154-156.
[2]	Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030[J]. J Bone Joint Surg Am, 2007, 89(4): 780-785.
[3]	Havelin LI, Fenstad AM, Salomonsson RA, et al. The Nordic arthroplasty register association a unique collaboration between 3 national hip arthroplasty registries with 280 201 THRs[J]. Acta Orthop, 2009, 80(4): 393-401.
[4]	B A. D H, A H. Antibiotic prophylaxis for wound infections in total joint arthroplasty：a systematic review[J]. J Bone Joint Surg, 2008, 90(7): 915-919.
[5]	陈志，周宗科．髋膝关节置换术后假体周围感染的诊治进展[J]．实用骨科杂志，2017，23(3):247-251.
[6]	Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee[J]. Ann Transl Med, 2015, 3(16): 233-234.
[7]	Aggarwal VK, Bakhshi H, Ecker NU, et al. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States[J]. J Knee Surg, 2014, 27(5): 399-405.
[8]	Jaberi FM, Parvizi J, Haytmanek C, et al. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty[J]. Clin Orthop Relat Res, 2008, 466(6): 1368-1371.
[9]	Cross MB, Yi PH, Thomas CF, et al. Evaluation of malnutrition in orthopaedic surgery[J]. J Am Acad Orthop Surg, 2014, 22(3): 193-199.
[10]	Guo JJ, Yang H, Qian H, et al. The effects of different nutritional measurements on delayed wound healing after hip fracture in the elderly[J]．J Surg Res, 2010, 159(1): 503-508.
[11]	Potter GD, Rao N, Mabry TM. Prevention of periprosthetic joint infection[J]. A Bone Joint Surg, 2015, 3(2): 72-81.
[12]	Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients：Relationship to postoperative wound complications[J]. J Arthroplasty, 1991, 6(4): 321-325.
[13]	Pitto RP. CORR insights (R): is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty？[J]. Clin Orthop Relat Res, 2015, 473(1): 183-184.
[14]	Zmistowski B, Tetreault MW, Alijanipour P, et al. Recurrent periprosthetic joint infection：persistent or new infection？[J]. J Arthroplasty, 2013, 28(9): 1486-1489.
[15]	Nawabi DH, Chin KF, Keen RW, et al. Vitamin D deficiency in patients with osteoarthritis undergoing total hip replacement: a cause for concern？[J]. J Bone Joint Surg Br, 2010, 92B(4): 496-499.
[16]	Maier GS, Horas K, Seeger JB, et al. Is there an association between periprosthetic joint infection and low vitamin D levels？[J]. Int Orthop, 2014, 38(7): 1499-1504.
[17]	Stryker LS, Abdel MP, Morrey ME, et al. Elevated postoperative blood glucose and preoperative hemoglobin a1C are associated with increased wound complications following total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95A(9): 808-814.
[18]	Capozzi JD, Lepkowsky ER, Callari MM, et al. The prevalence of diabetes mellitus and routine hemoglobin a1c screening in elective total joint arthroplasty patients[J]. J Arthroplasty, 2017, 32(1): 304-308.
[19]	Marchant J, Viens NA, Cook CA, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty[J]. J Bone Joint Surg Am, 2009, 91A(7): 1621-1629.
[20]	Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications[J]. Arch Surg, 2006, 141(4): 375-380.
[21]	Chrastil J, Anderson MB, Stevens V, et al. Is hemoglobin a1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty？[J]. J Arthroplasty, 2015, 30(7): 1197-1202.
[22]	Wang Y, Simpson JA, Wluka AE, et al. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis：a prospective cohort study[J]. Arthritis Res Ther, 2009, 11(2): 1-10.
[23]	Triantafyllopoulos GK, Soranoglou VG, Sculco TP, et al. Rate and risk factors for periprosthetic joint infection among 36, 494 primary total hip arthroplasties[J]. J Arthroplasty, 2018, 33(4): 1166-1170.
[24]	Tayton ER, Frampton C, Hooper GJ, et al. The impact of patient and surgical factors on the rate of infection after primary total knee arthroplasty: an analysis of 64 566 joints from the New Zealand Joint Registry[J]. Bone Joint J, 2016, 98B(3): 334-340.
[25]	Chirca I, Marculescu C. Prevention of infection in orthopedic prosthetic surgery[J]. Infect Dis Clin North Am, 2017, 31(2): 253-263.
[26]	Schnaser EA, Browne JA, Padgett DE, et al. Perioperative complications in patients with inflammatory arthropathy undergoing total knee arthroplasty[J]. J Arthroplasty, 2015, 30(10): 76-80.
[27]	Ravi B, Croxford R, Hollands S, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis[J]. Analyst, 2014, 66(2): 254-263.
[28]	Tada M, Inui K, Sugioka Y, et al. Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs[J]. Clin Rheumatol, 2016, 35(6): 1475-1481.
[29]	Ding T, Ledingham J, Luqmani R, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies[J]. Rheumatology, 2010, 49(11): 2217-2219.
[30]	Marculescu CE, Mabry T, Berbari EF. Prevention of surgical site infections in joint replacement surgery[J]. Surg Infect (Larchmt), 2016, 17(2): 152-157.
[31]	Kunutsor SK, Whitehouse MR, Blom AW, et al. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis[J/OL]. PLoS One, 2016, 11(3): e0150866. doi：10.1371/journal.pone.0150866.
[32]	Bozic KJ, Lau E, Kurtz S, et al. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA[J]. Clin Orthop Relat Res, 2012, 470(1): 130-137.
[33]	Leonard BE. The immune system, depression and the action of antidepressants[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2001, 25(4): 767-780.
[34]	Babayan RK. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy：a systematic review[J]. J Urol, 2012, 188(6): 2243-2244.
[35]	Teng SS, Yi CQ, Krettek C, et al. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies[J/OL]. PLoS One, 2015, 10(4): e0125294. doi: 10.1371/journal.pone.0125294.
[36]	Ban KA, Minei JP, Laronga CA, et al. Executive summary of the American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update[J]. Surg Infect (Larchmt), 2017, 18(4, SI): 379-382.
[37]	Bradley KA, Rubinsky AD, Sun HL, et al. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery[J]. J Gen Intern Med, 2011, 26(2): 162-169.
[38]	Tϕnnesen H, Nielsen PR, Lauritzen JB, et al. Smoking and alcohol intervention before surgery: evidence for best practice[J]. Br J Anaesth, 2009, 102(3): 297-306.
[39]	Rezapoor M, Parvizi J. Prevention of periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(6): 902-907.
[40]	George J, Klika AK, Higuera CA. Use of chlorhexidine preparations in total joint arthroplasty[J]. J Bone Jt Infect, 2017, 2(1): 15-22.
[41]	Colling K, Statz C, Glover J, et al. Pre-operative antiseptic shower and bath policy decreases the rate of S．aureus and methicillin-resistant S．aureus surgical site infections in patients undergoing joint arthroplasty[J]. Surg Infect (Larchmt), 2015, 16(2): 124-132.
[42]	Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial[J]. Crit Care Med, 2009, 37(6): 1858-1865.
[43]	Potter GD, Rao N, Mabry TM. Prevention of periprosthetic joint infection[J]. A Bone Joint Surg, 2017, 99-B(4 Supple B): 3-10.
[44]	Morrison TN, Chen AF, Taneja MA, et al. Single vs repeat surgical skin preparations for reducing surgical site infection after total joint arthroplasty: a prospective, randomized, double-blinded study[J]. J Arthroplasty, 2016, 31(6): 1289-1294.
[45]	Shahi A, Eajazi A. Prevention of periprosthetic joint infection: pre-and intraoperative considerations[J]. J Bone Joint Surg Br, 2015, 38(4): 219-221.
[46]	Broekman ML, Van Beijnum J, Peul WC. Neurosurgery and shaving: what’s the evidence? A review[J]. J Neurosurg, 2011, 115(4): 670-678.
[47]	Price CS, Williams A, Philips G, et al. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients[J]. Clin Orthop Relat Res, 2008, 466(11): 2842-2847.
[48]	Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of staphylococcus aureus[J]. N Engl J Med, 2010, 362(1): 9-17.
[49]	Grothe C, Taminato M, Belasco A, et al. Screening and treatment for staphylococcus aureus in patients undergoing hemodialysis: a systematic review and meta-analysis[J]. BMC Nephrol, 2014, 15(1): 202-205.
[50]	Botelho-Nevers E, Gagnaire J, Verhoeven PO, et al. Decolonization of staphylococcus aureus carriage[J]. Med Mal Infect, 2017, 47(5): 305-310.
[51]	Torres EG, Lindmair-Snell JM, Langan JW, et al. Is preoperative nasal povidone-iodine as efficient and cost-effective as standard methicillin-resistant staphylococcus aureus screening protocol in total joint arthroplasty？[J]. J Arthroplasty, 2016, 31(1): 215-218.
[52]	Parvizi J, Alijanipour P, Barberi EF, et al. Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections[J]. J Am Acad Orthop Surg, 2015, 23(Suppl): S32-S43.
[53]	Yang L, Zhou H, Cheng P, et al.A novel bivalent fusion vaccine induces broad immunoprotection against staphylococcus aureus infection in different murine models[J]. Clin Immunol, 2018, 188: 85-93.
[54]	Berbari EF, Osmon DR, Lahr B, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification[J]. Infect Cotrol Hosp Epidemiol, 2012, 33(8): 774-781.
[55]	J M, K WS, N MR, et al. Current evidence for the use of laminar flow in reducing infection rates in total joint arthroplasty[J]. Open Orthop J, 2015, 9(1): 495-498.
[56]	G P. AC B, C B. Influence of laminar airflow on prosthetic joint infections：a systematic review[J]. J Hosp Infect, 2012, 81(2): 73-78.
[57]	Panaahi P, Casper DS, Parvizi J, et al. Operating room traffic is a major concern during total joint arthroplasty[J]. Clin Orthop Relat Res, 2013, 471(1): 343-344.
[58]	Bedard M, Pelletier-Roy R, Angers-Goulet MA, et al. Traffic in the operating room during joint replacement is a multidisciplinary problem[J]. Can J Surg, 2015, 58(4): 232-236.
[59]	Guo YP, Wong PM, Li Y, et al. Is double-gloving really protective? A comparison between the glove perforation rate among perioperative nurses with single and double gloves during surgery[J]. Am J Surg, 2012, 204(2): 210-215.
[60]	Makama JG, Okeme IM, Makamae J, et al. Glove perforation rate in surgery: a randomized, controlled study to evaluate the efficacy of double dloving[J]. Surgl Infect, 2016, 17(4):420-436.
[61]	Heller S, Rezapoor M, Parvizi J. Minimising. the risk of infection: a peri-operative checklist[J]. Bone Joint J, 2016, 98B(1, A): 18-22.
[62]	Shohat N, Parvizi J. Prevention of periprosthetic joint infection: examining the recent guidelines[J]. J Arthroplasty, 2017, 32(7): 2040-2046.
[63]	Albuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty – a systematic review[J]. J Bone Joint Surg Br, 2008, 90B(7): 915-919.
[64]	Soriano A. CORR insights (R): vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin[J]. Clin Orthop Relat Res, 2017, 475(7): 1775-1778.
[65]	Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery[J]. Surg Infect (Larchmt), 2013, 14(1): 73-156.
[66]	Havelin LI, Engesaeter LB, Espehaug B, et al. The Norwegian Arthroplasty Register: 11 years and 73, 000 arthroplasties[J]. Acta Orthop Scand, 2000, 71(4): 337-353.
[67]	Wang J, Zhu C, Cheng T, et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty[J/OL]. PLoS One, 2013, 8(12): e82745. doi：10.1371/journal.pone.0082745.
[68]	Wang H, Qiu GX, Lin J, et al. Antibiotic bone cement cannot reduce deep infection after primary total knee arthroplasty[J]. Orthopedics, 2015, 38(6): e462-e466.
[69]	Miola M, Bistolfi A, Valsania MC, et al. Antibiotic-loaded acrylic bone cements：an in vitro study on the release mechanism and its efficacy[J]. Mater Sci Eng C Mater Biol Appl, 2013, 33(5): 302-305.
[70]	Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement[J]. J Bone Joint Surg Am, 2006, 88(11): 2487-2500.
[71]	Van DH, Neut D, Schenk W, et al. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation[J]. Acta Orthop Scand, 2000, 71(6): 625-629.
[72]	Kendall RW, Duncan CP, Smith JA, et al. Persistence of bacteria on antibiotic loaded acrylic depots.A reason for caution[J]．Clin Orthop Relat Res, 1996, 329(329): 273-280.
[73]	Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection[J]. Bone Joint J, 2013, 95-b(11): 1450-1452.
[74]	Catelas I, Wimmer MA, Utzschneider S. Polyethylene and metal wear particles: characteristics and biological effects[J]. Semin Immunopathol, 2011, 33(3): 257-271.
[75]	王寿宇，阴宝盛，张卫国．关节置换术后深部感染的预防[J/CD]．中华临床医师杂志(电子版)，2012，17)(17):5013-5015.
[76]	Cloutier M, Mantovani D, Rosei F. Antibacterial coatings: challenges, perspectives, and opportunities[J]. Trends Biotechnol, 2015, 33(11): 637-652.
[77]	Wang J, Li J, Guo G, et al. Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: new insight into the antimicrobial action of silver[J]. Scientific reports, 2016, 6: 326-399.
[78]	Guo G, Zhou H, Wang Q, et al. Nano-layered magnesium fluoride reservoirs on biomaterial surfaces strengthen polymorphonuclear leukocyte resistance to bacterial pathogens[J]. Nanoscale, 2017, 9(2): 875-892.
[79]	Zhu Y, Zhang F, Chen W, et al. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis[J]. J Hosp Infect, 2015, 89(2): 82-89.
[80]	Kapadia BH, Pivec R, Johnson AJ, et al. Infection prevention methodologies for lower extremity total joint arthroplasty[J]. Expert Rev Med Devices, 2013, 10(2): 215-224.
[81]	Hopper GP, Deakin AH, Crane EO, et al. Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit[J]. J Wound Care, 2012, 21(4): 200-203.
[82]	Grosso MJ, Berg A, Larussa S, et al. Silver-impregnated occlusive dressing reduces rates of acute periprosthetic joint infection after total joint arthroplasty[J]. J Arthroplasty, 2017, 32(3): 929-932.
[83]	Gillespie BM, Rickard CM, Thalib L, et al. Use of negative-pressure wound dressings to prevent surgical site complications after primary hip arthroplasty: a pilot RCT[J]. Surg Innov, 2015, 22(5): 488-495.
[84]	Mortazavi S, Hansen P, Zmistowski BA, et al. Hematoma following primary total hip arthroplasty: a grave complication[J]. J Arthroplasty, 2013, 28(3): 498-503.
[85]	de Dios-Pérez MS, Cordero-Ampuero J. Reply to: risk factors for infection in total knee arthroplasty, including previously unreported intraoperative fracture and deep venous thrombosis[J]. Rev Esp Cir Ortop Traumatol, 2016, 60(4):268-269.
[86]	Schousboe JT, Brown GA. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95(14): 1256-1264.
[87]	Huang R, Buckley PS, Scott B, et al. Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(9, S): 39-41.
[88]	Jenny JY. Infections associated with dental procedures in total hip arthroplasty[J]. J Bone Joint Surg Br, 2000, 82(2):56-59.

Please choose a citation manager

Content to export